Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson’s Disease

Background: Subthalamic nucleus deep brain stimulation (STN-DBS) is well-known to reduce medication burden in advanced stage Parkinson’s disease (PD). Preliminary data from a prospective, single blind, controlled pilot trial demonstrated that early stage PD subjects treated with STN-DBS also require...

Descripción completa

Detalles Bibliográficos
Autores principales: Hacker, Mallory L., Currie, Amanda D., Molinari, Anna L., Turchan, Maxim, Millan, Sarah M., Heusinkveld, Lauren E., Roach, Jonathon, Konrad, Peter E., Davis, Thomas L., Neimat, Joseph S., Phibbs, Fenna T., Hedera, Peter, Byrne, Daniel W., Charles, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927876/
https://www.ncbi.nlm.nih.gov/pubmed/26967937
http://dx.doi.org/10.3233/JPD-150712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927876/
https://www.ncbi.nlm.nih.gov/pubmed/26967937
http://dx.doi.org/10.3233/JPD-150712

Ejemplares similares